Clinical Trials Logo

Intensive Care clinical trials

View clinical trials related to Intensive Care.

Filter by:

NCT ID: NCT04173221 Completed - Shock Clinical Trials

Direct Assessment of Microcirculation In Shock (DAMIS)

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

Maintaining organ perfusion is the key to successful intensive care medicine. Shock is the most dangerous microcirculatory disorder and one of the most hazardous and lethal conditions of critically ill patients still showing high mortality rates. However, there are still ongoing controversies, how to assess microcirculation, how to predict outcome in time and how to guide specific therapy. Macrocirculation does not reflect microcirculation. Microcirculation reflects organ perfusion and correlates with the outcome. There is growing evidence that microcirculatory parameters are powerful tools to predict the outcome after cardiac arrest. Several guidelines use it as a target to guide therapy, but these recommendations base only on supporting evidence of low quality. Lactate is a late reflector of reduced organ perfusion and is of limited value for time-critical decision-making and their value as a therapeutic target. Sublingual sidestream dark-field (SDF) - measurement is a non-invasive method that reliably reflects organ perfusion. The last generation of microcirculation assessment tools are easy to use hand-held devices that use an automatic algorithm. In consequence, microcirculation has become a directly detectable physiological compartment. However, systematic investigations about this technology in shock are still lacking. DAMIS determines the value of directly assessed microcirculation on outcome in different types of shock. Therefore, this multicenter study will recruit up to 200 patients in shock. After the first measurement, patients will be randomized either to intervention or to control. The intervention consists in knowing microcirculatory parameters. A checklist will assist the treating physicians of the interventional group in explaining microcirculatory values and offering possible treatment options. Patients in the control group will be measured as well, but results will not be communicated to the treating physician.

NCT ID: NCT04169204 Active, not recruiting - Intensive Care Clinical Trials

Very Old Intensive Care Patients - Perfusion

VIPPER
Start date: May 19, 2020
Phase:
Study type: Observational

Shock is a frequent, etiologically heterogeneous and often lethal clinical condition of intensive care medicine. This is particularly true for very old intensive care patients (VIPs), who are among the fastest-growing subgroups of all intensive care unit (ICU) patients and who suffer from a significantly impaired outcome. In addition to the treatment of the causes of shock, current therapeutic approaches focus on the stabilization of vital parameters, which in general all reflect macrocirculatory measured values such as blood pressure. In contrast, a disturbance of the microcirculation (blood circulation of the smaller blood vessels <100 µm) is only poorly measurable and delayed. The last generation of AVA-Software (MicroVisionMedical) will calculate different parameters about the capillary densitiv and perfusion in a user-independent way. VIPPER investigates whether a non-invasive measurement of microcirculation using the sublingual mucosa in very old intensive care patients in shock leads to faster recognition and specific treatment of organ dysfunctions. Secondly, this study checks whether this measurement predicts outcome.

NCT ID: NCT04114747 Recruiting - Blood Pressure Clinical Trials

Renal Physiology During Continuous Renal Replacement Therapy

Start date: November 20, 2020
Phase: N/A
Study type: Interventional

Approximately 50% of patients in the intensive care unit (ICU) develop acute kidney injury (AKI) and more than 10% need dialysis. There is no treatment for AKI. Care is aiming for optimization of circulation and blood flow to the kidneys and avoiding nephrotoxic agents. There is conflicting data concerning whether early or late dialysis is harmful for the kidneys. No one has examined the physiological changes in the kidney when starting dialysis and which blood pressure that leads to most optimal physiological conditions for the kidneys during dialysis. In this descriptive study of 20 ICU patients suffering from AKI we aim to investigate renal physiology when starting continuous renal replacement therapy (CRRT) and also at different target blood pressures using retrograde renal vein thermodilution technique. In parallel we will also investigate and validate this invasive method with contrast enhanced ultrasound of the kidneys.

NCT ID: NCT03954522 Not yet recruiting - Clinical trials for Post Traumatic Stress Disorder

The Visiting Child and His Family in ICU

ENVIFAR
Start date: June 1, 2019
Phase: N/A
Study type: Interventional

According to literature, it's difficult to evaluate the impact of the visit of the child in ICU. Currently, no recommendations are available regarding welcome and accompany children who visit their relative hospitalized in ICU. Collaboration between humanities and medical sciences brings to this question a complementary look. Majority of studies investigated the question of the impact of young child ICU visit in a unidirectional linear causality scheme visit = psychopathological impact. The visit of the child in ICU should not be considered as an isolated event whose objective characteristics would be alone vectors of trauma. Contrary, the child visit must be apprehended in relation to the quality of the supports on which the child can count. The investigators hypothesize that children can overcome the visit of a kin hospitalized in ICU if accompanying people can support the child and contain, before and after the visit, the emotions of the child.

NCT ID: NCT03777150 Recruiting - Intensive Care Clinical Trials

Is There a Benefit of Postoperative ICU Management After Elective Surgery in Critical Ill Patients?

Start date: October 10, 2018
Phase: N/A
Study type: Interventional

Postoperative care of high risk patients in the Intensive Care Unit (ICU) has for long been considered to be the gold standard of care in terms of reducing perioperative mortality.New evidence from a 7-day cohort study involving 27 countries comes to question this practice. The primary objective of our study is to detect any benefit of postoperative ICU care after elective surgery in terms of patient's outcome, length of hospital stay, complications and cost.

NCT ID: NCT03626961 Completed - Intensive Care Clinical Trials

The Role of NEWS on Intensive Care Discharges

Start date: December 1, 2017
Phase:
Study type: Observational [Patient Registry]

To determine the ability of the NEWS at tertiary intensive care unit discharges to predict the development of clinical deterioration. To determine a cut-off value for NEWS score for early readmission

NCT ID: NCT03617796 Not yet recruiting - Clinical trials for Systemic Inflammatory Response Syndrome

Prognostic Value of CD64 Marker for Patients in Intensive Care Unit

CD64
Start date: September 10, 2018
Phase:
Study type: Observational

Among patients admitted to the intensive care unit (ICU), early recognition of those with the highest risk of death is of paramount importance. Since clinical judgment is sometimes uncertain biomarkers could provide additional information likely to guide critical illness management. We want to evaluate the prognostic value of leucocyte surface expression of CD64. Blood samples for CD64 biomarker measurement will be obtained daily during the patient's hospitalization. The primary outcome was all-cause death at D28 after admission

NCT ID: NCT03420417 Recruiting - Intensive Care Clinical Trials

Respiratory Mechanics in Intensive Care Patients

PREMIER
Start date: March 28, 2018
Phase: N/A
Study type: Interventional

This study aims at assessing the respiratory mechanics of intubated patients in intensive care unit.

NCT ID: NCT03368326 Completed - Brain Injuries Clinical Trials

Use of Critical-Care Pain Observation Tool and Bispectral Index for Detection of Pain in Brain Injured Patients

Start date: June 9, 2015
Phase: N/A
Study type: Observational

Brain injured patients are at high risk of pain due to the illness itself and a variety of nociceptive procedures in intensive care unit. Since the disorder of consciousness, speech, and movement, it is usually difficult for them to self-report the presence of pain reliably. The Critical-Care Pain observation Tool (CPOT) has been recommended for clinical use in the critically ill patients when self-report pain is unavailable. Besides, it seems that the bispectral index (BIS), a quantified electroencephalogram instrument, can be used for pain assessment along with the CPOT tool in some nonverbal critical ill patients (e.g., intubated and deep sedation). However, the validity and reliability of CPOT and BIS for pain assessment in brain injured patients are still uncertain so far. So the aim of this research is to investigate the value of CPOT and BIS for pain evaluation in this specific patient group.

NCT ID: NCT03335137 Completed - Intensive Care Clinical Trials

Determining Drug Levels of Beta-lactam Antibiotics in Severe Burned Patients

MSBV
Start date: May 1, 2014
Phase: N/A
Study type: Observational

At antibiotic stewardship of the University Hospital of Schleswig-Holsten it was noticed that there are much less studies measuring drug levels in severe burned patients than are required. Especially, severe burned patient developing a capillary leak might show lower drug levels than patients without a capillary leak. To compare drug levels of beta-lactam antibiotics, it is the aim of this study to measure pharmacokinetics of Piperacillin/Tazobactam in ICU patients with and without severe burns.